Antitumor Activity of Trastuzumab Deruxtecan in Pediatric Solid Tumors with Variable HER2 Expression.
- DOI
- 10.1158/1535-7163.mct-25-0437
- Published
- 2026 Jan 2
- Container
- Molecular cancer therapeutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/1535-7163.mct-25-0437,
title = {Antitumor Activity of Trastuzumab Deruxtecan in Pediatric Solid Tumors with Variable HER2 Expression.},
author = {Burke CM and Feinberg TY and Brosius S and Bhanot UK and Jain M and Linkov I and Siddiquee A and Guillan K and Ibáñez G and Ndengu AA and Calder P and Rosales N and Coutinho DF and Long MM and Fishkin R and Thyparambil S and Glade Bender JL and Reed DR and You D and Ortiz MV and Slotkin EK and Kung AL and Dela Cruz FS},
year = {2026},
journal = {Molecular cancer therapeutics},
doi = {10.1158/1535-7163.mct-25-0437},
url = {https://doi.org/10.1158/1535-7163.mct-25-0437}
}RIS
TY - JOUR TI - Antitumor Activity of Trastuzumab Deruxtecan in Pediatric Solid Tumors with Variable HER2 Expression. AU - Burke CM AU - Feinberg TY AU - Brosius S AU - Bhanot UK AU - Jain M AU - Linkov I AU - Siddiquee A AU - Guillan K AU - Ibáñez G AU - Ndengu AA AU - Calder P AU - Rosales N AU - Coutinho DF AU - Long MM AU - Fishkin R AU - Thyparambil S AU - Glade Bender JL AU - Reed DR AU - You D AU - Ortiz MV AU - Slotkin EK AU - Kung AL AU - Dela Cruz FS PY - 2026 JO - Molecular cancer therapeutics DO - 10.1158/1535-7163.mct-25-0437 UR - https://doi.org/10.1158/1535-7163.mct-25-0437 ER -
APA
CM, B., TY, F., S, B., UK, B., M, J., I, L., A, S., K, G., G, I., AA, N., P, C., N, R., DF, C., MM, L., R, F., S, T., JL, G. B., DR, R., D, Y., MV, O., EK, S., AL, K., & FS, D. C. (2026). Antitumor Activity of Trastuzumab Deruxtecan in Pediatric Solid Tumors with Variable HER2 Expression.. Molecular cancer therapeutics. https://doi.org/10.1158/1535-7163.mct-25-0437
Source records
- pubmed · retrieved 2026-09-27T07:34:39.269Z